StockTipsArenaBeta

BUY Cipla Ltd. — Siddharth Rai Mangala

BUYCipla Ltd.

bySiddharth Rai MangalaHorizon: Swing (≤2wk)20 Jul 2026via Zee Business (Live)

Entry₹1,461.5Inferred
Target₹1,500
Total upside +2.63% (call closed)
Stop loss₹1,430-2.16% risk
Exit₹1,43021 Jul 2026, 10:10 am
Stop-loss hit-2.16%
Follow Siddharth Rai Mangala for new calls(30% target hit, 89 closed calls)Get alertsWatch CIPLA for new buy/sell callsGet alertsSee 1 active Swing call on CIPLASee 10 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Jul 2026
3 supporting1 neutral0 opposing
Supports the BUY call (3)

Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street

NewsLivemint·20 Jul · today

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·20 Jul · today

4 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·7 Jul · 2w ago

Neutral / worth noting (1)

Cipla Arm Receives One USFDA Observation at New York Facility

NewsNdtv-Profit·18 Jul · 2d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.